We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
AI is one of the fastest-moving areas of technological advancement in government defence, bringing the capability to counter threats and create opportunities.
Partnership project turns back the clock on River Evenlode. Avian ‘paradise’ created in just six months.
Data on the real-world efficacy of the COVID-19 vaccines.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Information for patients, healthcare professionals and developers of new medicines
We have more than 10 years’ experience of successfully working with our customers to develop solutions across the radioactive waste lifecycle and provide access to the full range of treatment, logistics, and disposal techniques and technology in the UK, Europe,...
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
How to use a cost benefit analysis to evaluate your digital health product.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
How to arrange an effective external review of governance for your school or academy trust, and improve the performance of your board.
Advice on writing clear notices and maximising replies to your FSNs.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
The review of the safety of isotretinoin has concluded.
Using an ecological momentary assessment to evaluate your digital health product.
Guidance on choosing evaluation study types and methods.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).